Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Web-based Tailored Intervention to Improve the Quality of Life of Long-term Breast Cancer Survivors. A Randomized Controlled Trial

NCT05322460 is registered in ClinicalTrials.gov with Cristina García-Vivar as lead sponsor.

NCT NCT05322460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05322460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Web-based Tailored Intervention to Improve the Quality of Life of Long-term Breast Cancer Survivors. A Randomized Controlled Trial
Lead sponsor
Cristina García-Vivar
Phase
Not applicable
Overall status
Recruiting
Start date
December 15, 2023
Completion date
November 30, 2025
Enrollment
182 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long-term effects of cancer treatment, long-term effects secondary to cancer therapy in adults